Suppr超能文献

系统性硬化症中人类血管内皮的抗体依赖性细胞毒性

Antibody-dependent cellular cytotoxicity of human vascular endothelium in systemic sclerosis.

作者信息

Penning C A, Cunningham J, French M A, Harrison G, Rowell N R, Hughes P

出版信息

Clin Exp Immunol. 1984 Sep;57(3):548-56.

Abstract

Sera from 39 patients with systemic sclerosis were examined for a cytotoxic effect on human umbilical vein endothelium. Although none of the sera produced direct cytotoxicity of 51Cr-labelled endothelial cells, even with added complement, nine sera did produce increased 51Cr release when co-cultured with endothelial cells and normal human peripheral blood mononuclear cells. The effector cells involved in this cytotoxicity possessed Fc receptors but were non-T and non-adherent while the responsible serum factor(s) was present in IgG containing fractions. This cytotoxicity tended to occur in patients with both circulating immune complexes and precipitating antibodies to nuclear and cytoplasmic antigens who, as a group, had more severe and extensive visceral disease than those without such serological abnormalities. Control studies using sera from both 27 normal controls and 19 patients with either diabetes or extensive athero-sclerotic vascular disease failed to reveal any similar cytotoxicity.

摘要

检测了39例系统性硬化症患者血清对人脐静脉内皮细胞的细胞毒性作用。尽管即使添加补体,也没有一份血清对51Cr标记的内皮细胞产生直接细胞毒性,但有9份血清在与内皮细胞和正常人外周血单个核细胞共培养时,确实导致了51Cr释放增加。参与这种细胞毒性作用的效应细胞具有Fc受体,但不是T细胞且不黏附,而相关的血清因子存在于含IgG的组分中。这种细胞毒性作用倾向于发生在既有循环免疫复合物又有针对核和细胞质抗原的沉淀抗体的患者中,作为一个群体,他们比没有此类血清学异常的患者有更严重和广泛的内脏疾病。使用27名正常对照者以及19例糖尿病或广泛动脉粥样硬化血管疾病患者的血清进行的对照研究未发现任何类似的细胞毒性作用。

相似文献

6
Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity.
J Clin Invest. 1995 Dec;96(6):2569-77. doi: 10.1172/JCI118320.
8
Endothelial cell apoptosis in systemic sclerosis is induced by antibody-dependent cell-mediated cytotoxicity via CD95.
Arthritis Rheum. 2000 Nov;43(11):2550-62. doi: 10.1002/1529-0131(200011)43:11<2550::AID-ANR24>3.0.CO;2-H.

引用本文的文献

1
CAR-T cells in systemic sclerosis.
Clin Rheumatol. 2025 Jul 4. doi: 10.1007/s10067-025-07554-1.
2
Third-generation CD19.CAR-T cell-containing combination therapy in Scl70+ systemic sclerosis.
Ann Rheum Dis. 2024 Mar 12;83(4):543-546. doi: 10.1136/ard-2023-225174.
3
Can Antinuclear Antibodies Have a Pathogenic Role in Systemic Sclerosis?
Front Immunol. 2022 Jun 28;13:930970. doi: 10.3389/fimmu.2022.930970. eCollection 2022.
4
A system out of breath: how hypoxia possibly contributes to the pathogenesis of systemic sclerosis.
Int J Rheumatol. 2011;2011:824972. doi: 10.1155/2011/824972. Epub 2011 Nov 20.
5
Vascular disease in scleroderma.
Clin Rev Allergy Immunol. 2009 Jun;36(2-3):150-75. doi: 10.1007/s12016-008-8106-x.
7
Anti-endothelial cell antibodies in systemic sclerosis.
Clin Diagn Lab Immunol. 1999 Mar;6(2):156-60. doi: 10.1128/CDLI.6.2.156-160.1999.
8
Assessment of anti-endothelial cell antibodies in systemic sclerosis and Sjögren's syndrome.
Ann Rheum Dis. 1997 Apr;56(4):230-4. doi: 10.1136/ard.56.4.230.

本文引用的文献

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验